Since the blood glucose lowering effect of SGLT inhibition is minimal in the presence of euglycemia, and since the euglycemic action of these drugs is completely insulin independent, SGLT inhibitors might theoretically represent a valid adjunctive therapy in patients with type 1 diabetes. Here, INS is linked to type 1 diabetes mellitus.